Science Museum to host the 3rd International Symposium on Advances in Oncological Dermatology

Nov 13, 2006

 The Museo de las Ciencias Príncipe Felipe will host the 3rd International Symposium on Advances in Oncological Dermatology on 16th and 17th December, which will bring together 300 dermatologists from all over the world and will present all the latest developments in the diagnosis and treatment of cutaneous tumours.
Science Museum to host the 3rd International Symposium on Advances in Oncological Dermatology


The director of the Museo de las Ciencias, Manuel Toharia, accompanied by the scientific directors of the Symposium, doctors from the Valencia Institute of Oncology (IVO), Carlos Guillén, Onofre Sanmartín and Rafael Botella, pointed out that the Museum “is once again the host centre for high-level international scientific initiatives” and added that “by holding this type of specialist meeting, we are fulfilling one of the general aims of the Museum”.

For his part, the Head of IVO’s Dermatology Department and scientific director of the Symposium, Carlos Guillén, assured us that this third meeting, which attracts “the best experts in dermatology”, has this year had “an excellent response making us feel very proud as we are only dealing with a sub-specialism within general dermatology”.

At this year’s event, techniques such as Mohs micrographic surgery or photodynamic therapy will play a leading role. The latest treatments for actinic keratosis, cutaneous lymphomas or pigmented lesions are other subjects on which the participants at this Symposium will be sharing their knowledge. Doctor Andrés Crespo from Génopoïetic-AVAX in France will present the latest developments on metastasic melanoma using vaccines.

Doctor Ronald P. Rapini, a specialist from the Centre Against Anderson Cancer in Houston (Texas) will speak on the advantages of Mohs micrographic surgery, one of the techniques with the highest curing rate of malignant skin tumours compared to conventional methods.

For photodynamic therapy, doctor John Lear of Manchester University (U.K.) will explain why photodynamic therapy has become, in a very short period of time, a generally accepted treatment used by dermatologists to counter pre-cancerous and cancerous cutaneous lesions and in non-melanoma skincancer.

Symposium programme

On Thursday 16th November, from 9 a.m. to 10 a.m. there will be a round-table conference on “advances in metastasic melanoma using vaccines”, given by Andrés Crespo of Génopoïetic-AVAX of France. Then, from 11 a.m. to 12.30 a.m., John Lear will talk on diagnosis using fluorescence and photodynamic therapy. From 12.30 a.m. to 2 p.m., Timothy S. Brown of Louisville University will talk at the round-table conference entitled “Attitude towards difficult cutaneous tumours”.

In the afternoon, from 3.30 p.m. to 4.30 p.m., doctor Beatriz Llombart of IVO will present the latest developments in the diagnosis and treatment of dermafibrosarcoma. Later from 4.30 p.m. to 6 p.m., Eulalia Baselga from the University Hospital of Santa Creu y San Pau of Barcelona will take part in the round table conference entitled “Infant vascular tumours”. The round-table entitled “Up-date on micrographic surgery” from 6.30 p.m. to 8 p.m. will be addressed by Ronald P. Rapini, closing the first day of the Symposium.

The conference entitled “Actinic Keratosis vs in situ epidermoid carcinoma” will open the working day of Friday 17th November from 9 a.m. to 10.30 a.m. in the presence of Omar Sangueza of North Carolina University and Eggert Stockfleth of the University Hospital Charité of Berlin. From 11 a.m. to 12.30 a.m., Ronald P. Rapini will talk on the dermopathology of pigmented lesions. Finally from 12.30 p.m. to 1.30 p.m., Helmut Kerl of Graz university, Austria, will address the round table on “Diagnosis and treatment of cutaneous lymphomas”.